Jennifer Goldman
About Jennifer Goldman
Jennifer Goldman serves as the Director of Clinical and Development Finance at Deciphera Pharmaceuticals, where she has worked since 2016. She has extensive experience in finance roles within the pharmaceutical industry, having held positions at various companies including Takeda Oncology and Pfizer.
Current Role at Deciphera Pharmaceuticals
Jennifer Goldman serves as the Director of Clinical and Development Finance at Deciphera Pharmaceuticals. She has held this position since 2016, contributing to the financial oversight of clinical and development projects. Her role involves managing budgets, forecasting, and financial reporting to support the company's strategic initiatives in drug development. Deciphera Pharmaceuticals is located in Waltham, Massachusetts.
Previous Experience in Finance
Prior to her current role, Goldman accumulated extensive experience in finance within the pharmaceutical industry. She worked at Takeda Oncology from 2011 to 2012, focusing on clinical, non-clinical, and CMC finance. Additionally, she held the position of Director of Finance at Ligon Discovery for eight months in 2011. Her experience also includes roles at Karyopharm Therapeutics Inc. as a Clinical Finance Consultant and at Aveo Oncology as Director of Clinical Business Operations.
Educational Background
Goldman holds a Master of Business Administration (MBA) from Boston University, where she studied from 1987 to 1991. She also completed her undergraduate studies at Bryant University, earning a Bachelor of Science in Business Administration from 1983 to 1985. Additionally, she attended Michigan State University from 1980 to 1983, further enhancing her academic credentials.
Long-term Career in the Pharmaceutical Industry
Goldman's career in the pharmaceutical sector spans several years, beginning in 1993 at Pfizer, where she worked as a Finance Manager for 14 years. She then transitioned to various roles, including Associate Director of R&D Finance at Forum Pharmaceuticals from 2012 to 2015. Her diverse experiences across multiple organizations have equipped her with a comprehensive understanding of finance in clinical development.